Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | 33,332 | reported | 09 Feb 2026 | tx 7+1,130,908−3,297 |
| Trillium Therapeutics Inc. | 0 | reported | 17 Nov 2021 | tx 1−400,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Feb 2026 | SALE | Zentalis Pharmaceuticals, Inc. | 2,962 | 2.43 USD | |
| 09 Feb 2026 | SALE | Zentalis Pharmaceuticals, Inc. | 335 | 2.39 USD | |
| 08 Jan 2026 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 365,000 | 0.00 USD | deriv |
| 06 Feb 2025 | PURCHASE | Zentalis Pharmaceuticals, Inc. | 20,000 | 2.28 USD | |
| 03 Feb 2025 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 16,629 | 0.00 USD | |
| 03 Feb 2025 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 16,629 | 0.00 USD | deriv |
| 02 Dec 2024 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 712,650 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 400,000 | 0.00 USD | deriv |